Results 111 to 120 of about 220,169 (313)

Making climate change a national health priority: Australia's first National Health and Climate Strategy [PDF]

open access: bronze
Georgia Behrens   +4 more
openalex   +1 more source

24.H. Round table: AMR and cancer: cross-cutting priorities for an integrated public health and primary care approach [PDF]

open access: bronze, 2020
Organised by: EUPHA Infectious diseases section, EUPHA Chronic diseases section, WFPHA   +1 more
openalex   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

open access: yesMolecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster   +3 more
wiley   +1 more source

Carga de cáncer del departamento de Nariño y subregiones, Colombia, 2010

open access: yesRevista Facultad Nacional de Salud Pública, 2014
Resumen Objetivo: medir la carga de cáncer a partir del indicador Años de Vida Saludables Perdidos (avisa) en el Departamento de Nariño y subregiones.
Elizabeth Trujillo-Montalvo   +3 more
doaj  

Designing an evidence-informed package of essential health services for Universal Health Coverage: lessons learnt and challenges to implementation in Liberia

open access: yesBMJ Global Health
Liberia developed an evidence-informed package of health services for Universal Health Coverage (UHC) based on the Disease Control Priorities 3 evidence.
Hassan Haghparast-Bidgoli   +11 more
doaj   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy